Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy
Autor: | Andrea M. Corse, Mohamed H. Farah, Norman W. Barton, Christian Krarup, Lotte Risom, Christine í Dali, Mihai Moldovan, Luying Pan, Hongmei Cao, Jan-Eric Månsson, Nitin Nair, Marcia Sellos-Moura, Morten Duno |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Pathology
medicine.medical_specialty Arylsulfatase A business.industry General Neuroscience Central nervous system Axonal loss Sural nerve Anatomy medicine.disease Metachromatic leukodystrophy Cerebrospinal fluid medicine.anatomical_structure Somatosensory evoked potential medicine Neurology (clinical) Tibial nerve business Research Articles |
Zdroj: | Annals of Clinical and Translational Neurology |
ISSN: | 2328-9503 |
Popis: | Objective Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disorder due to deficient activity of arylsulfatase A (ASA) that causes accumulation of sulfatide and lysosulfatide. The disorder is associated with demyelination and axonal loss in the central and peripheral nervous systems. The late infantile form has an early-onset, rapidly progressive course with severe sensorimotor dysfunction. The relationship between the degree of nerve damage and (lyso)sulfatide accumulation is, however, not established. Methods In 13 children aged 2–5 years with severe motor impairment, markedly elevated cerebrospinal fluid (CSF) and sural nerve sulfatide and lysosulfatide levels, genotype, ASA mRNA levels, residual ASA, and protein cross-reactive immunological material (CRIM) confirmed the diagnosis. We studied the relationship between (lyso)sulfatide levels and (1) the clinical deficit in gross motor function (GMFM-88), (2) median and peroneal nerve motor and median and sural nerve sensory conduction studies (NCS), (3) median and tibial nerve somatosensory evoked potentials (SSEPs), (4) sural nerve histopathology, and (5) brain MR spectroscopy. Results Eleven patients had a sensory-motor demyelinating neuropathy on electrophysiological testing, whereas two patients had normal studies. Sural nerve and CSF (lyso)sulfatide levels strongly correlated with abnormalities in electrophysiological parameters and large myelinated fiber loss in the sural nerve, but there were no associations between (lyso)sulfatide levels and measures of central nervous system (CNS) involvement (GMFM-88 score, SSEP, and MR spectroscopy). Interpretation Nerve and CSF sulfatide and lysosulfatide accumulation provides a marker of disease severity in the PNS only; it does not reflect the extent of CNS involvement by the disease process. The magnitude of the biochemical disturbance produces a continuously graded spectrum of impairments in neurophysiological function and sural nerve histopathology. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |